Quest Diagnostics price target raised to $180 from $165 at Piper Sandler
Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...
Earnings call transcript: Quest Diagnostics Q4 2024 beats EPS forecast
Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...
Mizuho lifts Quest Diagnostics target to $178 on strong outlook
Securities showed confidence in Quest Diagnostics (NYSE:DGX) by increasing the company's price target to $178 from the ...
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
Truist Financial analyst David S Macdonald reiterated a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target ...